Home LiteratureArticle Details
PMID: 16447112 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America ·Vol. 42 ·No. 5 ·2006-03-01 ·Pages 669-72

Hagan H, Latka MH, Campbell JV, Golub ET, Garfein RS, Thomas DA, Kapadia F, Strathdee SA, Study to Reduce Intravenous Exposures Project Team

Abstract

Among 404 injection drug users aged 18-35 who tested positive for hepatitis C virus (HCV) RNA, 96% had conditions that are potentially unwarranted contraindications for HCV treatment (e.g., problem drinking, moderate-to-severe depression, and recent drug injection). Restrictive eligibility criteria may deny treatment to a large proportion of patients who could benefit from it.

MeSH Terms
Adolescent Adult Antiviral Agents/therapeutic use Hepatitis C/drug therapy,epidemiology Humans Patient Selection RNA, Viral/blood Risk Factors Substance Abuse, Intravenous United States
Chemicals
Antiviral Agents RNA, Viral
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Hagan Holly
National Development and Research Institutes, Center for Drug Use and HIV Research, New York, NY, 10010, USA. [email protected]
Latka Mary H
Campbell Jennifer V
Golub Elizabeth T
Garfein Richard S
Thomas David A
Kapadia Farzana
Strathdee Steffanie A
Study to Reduce Intravenous Exposures Project Team
Article Info
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Abbr.
Clin Infect Dis
ISSN
1537-6591
DOI
10.1086/499951
Email
[email protected]
Published
2006-03-01
Epub
2006-00-20
Pages
669-72
Language
English
Region
United States
NLM ID
9203213
Subset
IM
Grants
NIDA NIH HHS · DA14499 · United States
Corrections
ErratumIn
-
CommentIn
PMID: 16447113
External Links
PubMed source DOI: 10.1086/499951 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2